NEFL and Alzheimer disease: The core blood biomarkers of AD include Aβ42 (or Aβ42/40 ratio), phosphorylated tau181 (p‐tau181), neurofilament light chain (NfL), and total tau (T‐tau), which reflect Aβ pathology, tau pathology, and neuronal damage, respectively.5, 6